Pre-prostatectomy membranous urethral length as a predictive factor of post prostatectomy incontinence requiring surgical intervention with an artificial urinary sphincter or a male sling.


Journal

Neurourology and urodynamics
ISSN: 1520-6777
Titre abrégé: Neurourol Urodyn
Pays: United States
ID NLM: 8303326

Informations de publication

Date de publication:
04 2022
Historique:
revised: 30 12 2021
received: 03 11 2021
accepted: 15 01 2022
pubmed: 11 3 2022
medline: 30 4 2022
entrez: 10 3 2022
Statut: ppublish

Résumé

To ascertain whether the membranous urethral length (MUL) is predictive of postprostatectomy incontinence (PPI) that requires surgery such as artificial urinary sphincter (AUS) or male sling (MS). Men who had undergone AUS or MS for PPI were identified from a prospectively maintained database and compared to a control group of men who were continent at 12 months after radical prostatectomy. MUL in sagittal and coronal planes, sphincter height and width were measured on prebiopsy T2-weighted MRI scans. Sphincter volume was estimated as an ellipsoid cylinder. A total of 95 patients (64 AUS and 31 MS) were compared to 60 continent controls. There was no statistical difference in presenting PSA, prostate volume, and T-stage. The mean MUL in sagittal and coronal planes was 11.31 mm (SD: 2.6, range: 6-17 mm) and 11.43 mm (SD: 2.94, range: 5-17 mm) in patients who had AUS and MS, respectively; 15.23 mm (SD: 4.2, range: 8.25-25 mm) and 15.75 mm (SD: 4.1, range: 8-24 mm) in controls (p < 0.01). No men in the PPI surgery group had an MUL >17 mm compared to 35% (20/57 sagittal, 20/58 coronal) of controls. The odds ratio for requiring surgery for PPI was 13.4 for sagittal MUL <9 mm and 3.2 if the MUL <12 mm. Patients who had surgery for PPI had a significantly shorter MUL and sphincter volume than continent controls. Men with an MUL >17 mm are unlikely to require surgery for PPI whereas an MUL <12 mm significantly increases the risk of requiring surgery for PPI. MUL should be considered when discussing treatment options for prostate cancer.

Identifiants

pubmed: 35266177
doi: 10.1002/nau.24904
pmc: PMC9313820
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

973-979

Commentaires et corrections

Type : ErratumIn

Informations de copyright

© 2022 The Authors. Neurourology and Urodynamics published by Wiley Periodicals LLC.

Références

Neurourol Urodyn. 2022 Apr;41(4):973-979
pubmed: 35266177
Turk J Urol. 2014 Mar;40(1):1-8
pubmed: 26328137
World J Surg Oncol. 2018 Nov 16;16(1):224
pubmed: 30445961
Indian J Urol. 2007 Apr;23(2):174-9
pubmed: 19675796
Eur Urol. 2017 Mar;71(3):368-378
pubmed: 27394644
Rev Urol. 2014;16(4):181-8
pubmed: 25548545
Sci Rep. 2021 Jan 19;11(1):1759
pubmed: 33469136
N Engl J Med. 2018 May 10;378(19):1767-1777
pubmed: 29552975
Urology. 2006 Jul;68(1):137-41
pubmed: 16777192
J Urol. 2012 Mar;187(3):945-50
pubmed: 22264458
Neurourol Urodyn. 2013 Sep;32(7):957-63
pubmed: 23371847
BMC Urol. 2020 Jan 31;20(1):8
pubmed: 32005113
J Int Med Res. 2018 Jan;46(1):421-429
pubmed: 28718690
Eur J Radiol. 2019 Nov;120:108668
pubmed: 31546125
Eur Urol Focus. 2016 Aug;2(3):245-259
pubmed: 28723370

Auteurs

Priyanka Oza (P)

Department of Urology, Guy's Hospital, Guy's and St Thomas' NHS Foundation Trust, London, UK.
Faculty of Life Sciences & Medicine, King's College London, London, UK.

Nicholas Faure Walker (NF)

Department of Urology, King's College NHS Foundation Trust, London, UK.

Giles Rottenberg (G)

Department of Radiology, Guy's and St Thomas' NHS Foundation Trust, London, UK.

Findlay MacAskill (F)

Department of Urology, Guy's Hospital, Guy's and St Thomas' NHS Foundation Trust, London, UK.

Sachin Malde (S)

Department of Urology, Guy's Hospital, Guy's and St Thomas' NHS Foundation Trust, London, UK.

Claire Taylor (C)

Department of Urology, Guy's Hospital, Guy's and St Thomas' NHS Foundation Trust, London, UK.

Arun Sahai (A)

Department of Urology, Guy's Hospital, Guy's and St Thomas' NHS Foundation Trust, London, UK.
Faculty of Life Sciences & Medicine, King's College London, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH